These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8027975)

  • 21. Scalar coupling across [C-H···F-C] interactions in (σ-aryl)-chelating post-metallocenes.
    So LC; Liu CC; Chan MC; Lo JC; Sze KH; Zhu N
    Chemistry; 2012 Jan; 18(2):565-73. PubMed ID: 22161818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of metal ions with DNA, its constituents and derivatives, which may be relevant for anticancer research.
    Turel I; Kljun J
    Curr Top Med Chem; 2011; 11(21):2661-87. PubMed ID: 22039873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrolytic metal with a hydrophobic periphery: titanium(IV) complexes of naphthalene-2,3-diolate and interactions with serum albumin.
    Tinoco AD; Eames EV; Incarvito CD; Valentine AM
    Inorg Chem; 2008 Sep; 47(18):8380-90. PubMed ID: 18710217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.
    Köpf-Maier P; Hesse B; Voigtländer R; Köpf H
    J Cancer Res Clin Oncol; 1980; 97(1):31-9. PubMed ID: 7400205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
    Bhattacharyya S; Purkait K; Mukherjee A
    Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstrand DNA covalent binding of two dinuclear Ru(ii) complexes. Influence of the extra ring of the bridging ligand on the DNA interaction and cytotoxic activity.
    Lozano HJ; Busto N; Espino G; Carbayo A; Leal JM; Platts JA; García B
    Dalton Trans; 2017 Mar; 46(11):3611-3622. PubMed ID: 28243638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10703-13. PubMed ID: 12940756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molybdenocene-oligonucleotide binding study at physiological pH using NMR spectroscopy and cyclic voltammetry.
    Vera JL; Román FR; Meléndez E
    Bioorg Med Chem; 2006 Dec; 14(24):8683-91. PubMed ID: 16945539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of isomeric equilibria formed by metal ion complexes of 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine (8,8aPMEA) and 9-[2-(phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA). Derivatives of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
    Gómez-Coca RB; Kapinos LE; Holý A; Vilaplana RA; González-Vílchez F; Sigel H
    J Biol Inorg Chem; 2004 Dec; 9(8):961-72. PubMed ID: 15503234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA.
    Chifotides HT; Dunbar KR
    Acc Chem Res; 2005 Feb; 38(2):146-56. PubMed ID: 15709734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synthesis, structure and reactivity of B(C6F5)3-stabilised amide (M-NH2) complexes of the group 4 metals.
    Mountford AJ; Clegg W; Coles SJ; Harrington RW; Horton PN; Humphrey SM; Hursthouse MB; Wright JA; Lancaster SJ
    Chemistry; 2007; 13(16):4535-47. PubMed ID: 17295366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
    J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.
    Guo M; Sun H; McArdle HJ; Gambling L; Sadler PJ
    Biochemistry; 2000 Aug; 39(33):10023-33. PubMed ID: 10955990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spermicidal activity of metallocene complexes containing vanadium(IV) in humans.
    D'Cruz OJ; Ghosh P; Uckun FM
    Biol Reprod; 1998 Jun; 58(6):1515-26. PubMed ID: 9623614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chelating σ-Aryl Post-Metallocenes: Probing Intramolecular [C-H···F-C] Interactions and Unusual Reaction Pathways.
    Liu CC; Chan MC
    Acc Chem Res; 2015 Jun; 48(6):1580-90. PubMed ID: 25993345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleobase-containing transition metal complexes as building blocks for biological markers and supramolecular structures.
    Lynam JM
    Dalton Trans; 2008 Aug; (31):4067-78. PubMed ID: 18688423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor metallocenes: new developments and toxicologic features.
    Köpf-Maier P; Köpf H
    Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordination site-dependent cation binding and multi-responsible redox properties of Janus-head metalloligand, [Mo(V)(1,2-mercaptophenolato)3].
    Matsumoto T; Wakizaka M; Yano H; Kobayashi A; Chang HC; Kato M
    Dalton Trans; 2012 Jul; 41(27):8303-15. PubMed ID: 22491744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.